Evidence map›Paper›PMID 37525647›Full record

ArticleInternational journal of general medicine2023

Systemic Immune-Inflammation and Systemic Inflammation Response Indices are Predictive Markers of Mortality in Inpatients Internal Medicine Services.

Betül Çavuşoğlu Türker, Süleyman Ahbab, Fatih Türker, Emre Hoca, Ece Çiftçi Öztürk, Atay Can Kula, Hüseyin Öztürk, Ayşe Öznur Urvasızoğlu, Merve Bulut, Özge Yasun and 1 more

Abstract read
In one paragraph

Article in International journal of general medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Systemic immune inflammation index with all-cause and cause-specific mortality: a meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Betül Çavuşoğlu TürkerDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.
Süleyman AhbabDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.
Fatih TürkerDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0002-8281-0319
Emre HocaDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.
Ece Çiftçi ÖztürkDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.
Atay Can KulaInternal Medicine Department, Ivrindi State Hospital, Balıkesir, Turkey.
Hüseyin ÖztürkDepartment of Internal Medicine, University of Health Sciences, Başakşehir Çam ve Sakura City Hospital, İstanbul, Turkey.
Ayşe Öznur UrvasızoğluDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.
Merve BulutDepartment of Internal Medicine, University of Health Sciences, Gaziosmanpaşa Taksim Health Training and Research Hospital, İstanbul, Turkey.
Özge YasunInternal Medicine Department, Hakkari State Hospital, Hakkari, Turkey.ORCID 0000-0002-8147-7374
Hayriye Esra AtaoğluDepartment of Internal Medicine, University of Health Sciences, Haseki Health Training and Research Hospital, İstanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Internal medicine services serve the patient population with many chronic diseases. Therefore, it is high mortality rates compared to other departments of the hospital. Estimating the prognostic risk of hospitalized patients may be useful in mortality for patients. İn this study, we evaluated the level of Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) and its association with mortality in inpatients. Patients and methods: This study was performed in 2218 patients who were hospitalized between January 1st-December 31th of 2019. Patients were followed up for three years about primary endpoint as all-cause (except for unnatural deaths) mortality. Participants were divided into 4 equal groups according to their increasing levels of SII and SIRI. (Quartile 1-4) Age, gender, diabetes mellitus, hypertension, coronary artery disease, chronic kidney disease, malignancies (solid), white blood cell, neutrophil, lymphocyte, monocytes, hemoglobin, hematocrit, platelet, CRP, albumin, Systemic Inflammation Response Index (Quartile 1-4), Systemic Immune Inflammation Index (Quartile 1-4) were compared between survival and non-survival groups. Results: There were 1153 female and 1065 male participants enrolled. Compared with surviving patients, patients who died were older and had a higher prevalence of diabetes mellitus, hypertension, malignancy, chronic kidney disease and coronary artery disease (p < 0.001). There was a lower proportion of female patients among the patients who died. Compared to the survivor group, group who died exhibited a significant increase in CRP level, neutrophil, white blood cell and monocyte counts, but had a lower lymphocyte count, albumin level and hemoglobin count (P < 0.001). Results of Cox regression analysis showed that age, chronic kidney disease, malignancy, SIRI quartile 3, 4 and SII quartile 3, 4 pointed out a close relationship with mortality risk. (P < 0.001). Conclusion: The SIRI and SII have indicated the clinical importance of as novel markers for predicting mortality in inpatients.

Indexed as

internal medicine inpatientsmortalitySIISIRI

Identifiers

PMID37525647
PMCPMC10387250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.